Filgrastim Completed Phase 2 Trials for Wilms' tumor Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00187031A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor